266 related articles for article (PubMed ID: 38084101)
1. Genome-wide CRISPR/Cas9 screening for drug resistance in tumors.
Zhang Z; Wang H; Yan Q; Cui J; Chen Y; Ruan S; Yang J; Wu Z; Han M; Huang S; Zhou Q; Zhang C; Hou B
Front Pharmacol; 2023; 14():1284610. PubMed ID: 38084101
[TBL] [Abstract][Full Text] [Related]
2. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements.
Liu SY; Yi GQ; Tang ZL; Chen B
Yi Chuan; 2020 May; 42(5):435-443. PubMed ID: 32431295
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 for overcoming drug resistance in solid tumors.
Saber A; Liu B; Ebrahimi P; Haisma HJ
Daru; 2020 Jun; 28(1):295-304. PubMed ID: 30666557
[TBL] [Abstract][Full Text] [Related]
4. [The application of CRISPR/Cas9 genome editing technology in cancer research].
Wang DY; Ma N; Hui Y; Gao X
Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
[TBL] [Abstract][Full Text] [Related]
5. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer.
Yang H; Liu B; Liu D; Yang Z; Zhang S; Xu P; Xing Y; Kutschick I; Pfeffer S; Britzen-Laurent N; Grützmann R; Pilarsky C
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804923
[TBL] [Abstract][Full Text] [Related]
7. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 Based Genome Editing in Wheat.
Smedley MA; Hayta S; Clarke M; Harwood WA
Curr Protoc; 2021 Mar; 1(3):e65. PubMed ID: 33687760
[TBL] [Abstract][Full Text] [Related]
9. [The role of CRISPR screening in leukemia research].
Oshima K
Rinsho Ketsueki; 2022; 63(11):1580-1585. PubMed ID: 36476800
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9: a powerful tool in colorectal cancer research.
Hu Y; Liu L; Jiang Q; Fang W; Chen Y; Hong Y; Zhai X
J Exp Clin Cancer Res; 2023 Nov; 42(1):308. PubMed ID: 37993945
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F; Wen Y; Guo X
Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
[TBL] [Abstract][Full Text] [Related]
12. The evolution of CRISPR/Cas9 and their cousins: hope or hype?
Bhushan K; Chattopadhyay A; Pratap D
Biotechnol Lett; 2018 Mar; 40(3):465-477. PubMed ID: 29344851
[TBL] [Abstract][Full Text] [Related]
13. Genome-scale CRISPR-Cas9 knockout screening in human cells.
Shalem O; Sanjana NE; Hartenian E; Shi X; Scott DA; Mikkelson T; Heckl D; Ebert BL; Root DE; Doench JG; Zhang F
Science; 2014 Jan; 343(6166):84-87. PubMed ID: 24336571
[TBL] [Abstract][Full Text] [Related]
14. Advance of Clustered Regularly Interspaced Short Palindromic Repeats-Cas9 System and Its Application in Crop Improvement.
Rao Y; Yang X; Pan C; Wang C; Wang K
Front Plant Sci; 2022; 13():839001. PubMed ID: 35645999
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
[TBL] [Abstract][Full Text] [Related]
17. Clustered regularly interspaced palindromic repeats-cas9-based strategies towards HIV eradication: A literature review.
Miranda AV; Wiyono L; Nurachman LA
J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S134-S139. PubMed ID: 33785958
[TBL] [Abstract][Full Text] [Related]
18. Effect of CRISPR/Cas9-Edited PD-1/PD-L1 on Tumor Immunity and Immunotherapy.
Xu Y; Chen C; Guo Y; Hu S; Sun Z
Front Immunol; 2022; 13():848327. PubMed ID: 35300341
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide CRISPR Screening for the Identification of Therapy Resistance-Associated Genes in Urothelial Carcinoma.
Mantwill K; Nawroth R
Methods Mol Biol; 2023; 2684():155-165. PubMed ID: 37410233
[TBL] [Abstract][Full Text] [Related]
20. The CRISPR/Cas9 system and its applications in crop genome editing.
Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
